Publication Name	World Journal of Hepatology
Manuscript ID	13614
Country	Brazil

Received	2014-08-28 08:14
Peer-Review Started	2014-08-29 08:14
To Make the First Decision	2014-10-14 18:08
Return for Revision	2014-10-20 17:26
Revised	2014-10-30 06:25
Second Decision	2014-12-10 20:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-12-17 16:26
Articles in Press	2014-12-17 16:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-20 12:12
Publish the Manuscript Online	2015-03-31 15:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Silvia Marinho Ferolla, Geyza Nogueira de Almeida Armiliato, Cláudia Alves Couto and Teresa Cristina Abreu Ferrari
Funding Agency and Grant Number
Corresponding Author	Silvia Marinho Ferolla, MSc, Centro de Pós-Graduação, Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Av, Professor Alfredo Balena 190, 30130-100 Belo Horizonte, Minas Gerais, Brazil. contato@silviaferolla.com.br
Key Words	Fatty liver; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Probiotic; Intestinal microbiota
Core Tip	Nonalcoholic fatty liver disease (NAFLD) is an important cause of chronic liver disease. Its pathogenesis is largely unknown, and until nowadays there is no effective treatment for this disorder. Recent evidence from animal and human studies suggests that gut microbiota may play a role in the development of NAFLD. Furthermore, some data indicate that probiotics may be beneficial in NAFLD treatment. In this context, we conducted a systematic review on the use of probiotics in the treatment of NAFLD and discuss the effects of these agents and their efficacy as an emerging therapeutic resource to treat NAFLD patients.
Publish Date	2015-03-31 15:58
Citation	Ferolla SM, Armiliato GNA, Couto CA, Ferrari TCA. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol 2015; 7(3): 559-565
URL	http://www.wjgnet.com/1948-5182/full/v7/i3/559.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i3.559

Full Article (PDF)	WJH-7-559.pdf
Full Article (Word)	WJH-7-559.doc
Manuscript File	13614-Review.doc
Answering Reviewers	13614-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13614-Conflict-of-interest statement.pdf
Copyright License Agreement	13614-Copyright assignment.pdf
Peer-review Report	13614-Peer review(s).pdf
Scientific Misconduct Check	13614-CrossCheck.jpg
Scientific Editor Work List	13614-Scientific editor work list.pdf